ADHD, Trauma, Nutrition, and Infrastructure: Misdiagnosis, Excitotoxicity, and the Gut–Brain Axis

Micronutrient deficiencies are among the most overlooked contributors to cognitive and behavioral symptoms that resemble ADHD. Magnesium, vitamin B6, B12, and B1 play essential roles in neurotransmitter synthesis, mitochondrial function, and glutamate regulation. Deficits in these nutrients impair dopamine and norepinephrine production, weaken inhibitory GABA signaling, and increase vulnerability to excitotoxic stress. These pathways overlap directly with the neurobiology of ADHD, yet nutritional assessment is rarely included in diagnostic protocols. Magnesium deficiency, for example, is associated with irritability, restlessness, sleep disruption, and impaired attention—symptoms that closely mirror ADHD presentations. Vitamin B6 is required for the synthesis of serotonin, dopamine, and GABA; low levels can produce mood instability, impulsivity, and cognitive slowing. B12 and B1 deficiencies can cause fatigue, memory impairment, and executive dysfunction. These physiological effects are well‑documented across the psychiatric literature, yet they remain structurally invisible within ADHD assessment frameworks. The result is a diagnostic blind spot: symptoms arising from nutritional deficits are interpreted as evidence of a fixed neurodevelopmental disorder. This is not a failure of clinicians but a failure of infrastructure. Diagnostic guidelines emphasize behavioral checklists and pharmaceutical response, while nutritional testing is excluded from coverage. Families are rarely informed that micronutrient deficits can produce ADHD‑like symptoms, and clinicians lack the institutional support to investigate these pathways. The system is designed to identify ADHD, not to differentiate it from conditions that mimic it. This structural omission reinforces pharmaceutical dependency. When nutritional contributors go untested, stimulant response becomes the primary diagnostic tool. If symptoms improve, the diagnosis is confirmed; if they do not, dosage adjustments or additional medications follow. In both cases, the underlying physiological contributors remain unaddressed. The infrastructure is optimized for containment, not resolution.